Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Gains from Investment Securities: 2022-2023

Historic Gains from Investment Securities for Therapeutics (LENZ) over the last 1 years, with Sep 2023 value amounting to $10,367.

  • Therapeutics' Gains from Investment Securities was N/A to $10,367 in Q3 2023 from the same period last year, while for Sep 2023 it was $339,422, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is 624.74% up from last year.
  • According to the latest figures from Q3 2023, Therapeutics' Gains from Investment Securities is $10,367, which was down 94.04% from $174,000 recorded in Q2 2023.
  • Therapeutics' Gains from Investment Securities' 5-year high stood at $174,000 during Q2 2023, with a 5-year trough of $10,367 in Q3 2023.
  • For the 2-year period, Therapeutics' Gains from Investment Securities averaged around $76,673, with its median value being $43,945 (2022).
  • Data for Therapeutics' Gains from Investment Securities shows a peak YoY spiked of 295.95% (in 2023) over the last 5 years.
  • Therapeutics' Gains from Investment Securities (Quarterly) stood at $139,055 in 2022, then skyrocketed by 295.95% to $10,367 in 2023.
  • Its last three reported values are $10,367 in Q3 2023, $174,000 for Q2 2023, and $16,000 during Q1 2023.